Showing 76–100 of 238 international scientific journals (Oncology)
| Rank | Journal Name & ISSN | Country | WoS Quartile | CAS Division | Impact Factor | Scopus SJR | H-Index | Docs/yr | Self-Citation | Publisher | Profile |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 76 | Breast Cancer ISSN: 1340-6868 / 1880-4233 | 🇯🇵Japan | Q1 | CAS Tier 3 | 3.7 | 1.036Q1 | 47 | 106 | 2.5% | Springer Japan | Profile |
| 77 | Clinical & Experimental Metastasis ISSN: 0262-0898 / 1573-7276 | 🇳🇱Netherlands | Q2 | CAS Tier 3 | 3.7 | 1.187Q1 | 92 | 67 | 2.4% | Springer Netherlands | Profile |
| 78 | Breast Cancer-Targets and Therapy ISSN: 1179-1314 | 🇬🇧United Kingdom | Q2 | CAS Tier 4 | 3.6 | 0.992Q2 | — | 54 | 3% | Dove Medical Press | Profile |
| 79 | Current Oncology ISSN: 1198-0052 / 1718-7729 | 🌐Canada | Q2 | CAS Tier 3 | 3.6 | 1.132Q2 | 42 | 437 | 7.1% | Multimed Inc. | Profile |
| 80 | JCO Clinical Cancer Informatics ISSN: 2473-4276 | 🌐International | Q2 | CAS Tier 3 | 3.6 | 1.174Q1 | — | 75 | 15.2% | American Society of Clinical Oncology | Profile |
| 81 | Journal of Bone Oncology ISSN: 2212-1374 | 🇩🇪Germany | Q2 | CAS Tier 3 | 3.6 | 1.087Q2 | — | 75 | 3.2% | Elsevier GmbH | Profile |
| 82 | Journal of Bone Oncology ISSN: 2212-1366 | 🌐International | Q2 | CAS Tier 3 | 3.6 | — | 15 | 62 | 3.2% | Updating | Profile |
| 83 | Journal of Breast Cancer ISSN: 1738-6756 | 🌐South Korea | Q2 | CAS Tier 4 | 3.6 | 0.89Q2 | 29 | 52 | 4.5% | Korean Breast Cancer Society | Profile |
| 84 | JTO Clinical and Research Reports ISSN: 2666-3643 | 🇺🇸United States | Q2 | CAS Tier 2 | 3.6 | 1.708Q1 | — | 108 | 3.3% | Elsevier | Profile |
| 85 | Precision Radiation Oncology ISSN: 2398-7324 | 🌐Australia | Q1 | CAS Tier 4 | 3.6 | 0.746Q2 | — | 41 | N/A | Wiley | Profile |
| 86 | Radiation Oncology ISSN: 1748-717X | 🇬🇧United Kingdom | Q2 | CAS Tier 2 | 3.6 | 1.05Q1 | 58 | 236 | 6.1% | BioMed Central | Profile |
| 87 | World Journal of Clinical Oncology ISSN: 2218-4333 | 🇺🇸United States | Q2 | CAS Tier 3 | 3.6 | — | — | 89 | 0% | Baishideng Publishing Group | Profile |
| 88 | Cancer Medicine ISSN: 2045-7634 | 🇺🇸United States | Q2 | CAS Tier 3 | 3.5 | 1.156Q1 | 34 | 772 | 3.4% | John Wiley and Sons Ltd | Profile |
| 89 | Cancer Treatment and Research Communications ISSN: 2468-2942 | 🇬🇧United Kingdom | Q2 | CAS Tier 4 | 3.5 | 0.995Q2 | — | 320 | N/A | Elsevier | Profile |
| 90 | Cancer Prevention Research ISSN: 1940-6207 / 1940-6215 | 🇺🇸United States | Q2 | CAS Tier 3 | 3.4 | 1.129Q1 | 80 | 102 | 3.4% | American Association for Cancer Research Inc. | Profile |
| 91 | Journal of Cancer ISSN: 1837-9664 | 🌐Australia | Q2 | CAS Tier 3 | 3.4 | 0.852Q2 | 42 | 710 | 0% | Ivyspring International Publisher | Profile |
| 92 | Journal of Cancer Survivorship ISSN: 1932-2259 / 1932-2267 | 🇺🇸United States | Q2 | CAS Tier 2 | 3.4 | 1.151Q1 | 53 | 155 | 6.5% | Springer US | Profile |
| 93 | Oncology and Therapy ISSN: 2366-1070 / 2366-1089 | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 3.4 | 1.159Q2 | — | 42 | 0% | Adis, Springer Healthcare | Profile |
| 94 | Translational Lung Cancer Research ISSN: 2218-6751 | 🌐Hong Kong | Q2 | CAS Tier 3 | 3.4 | 0.987Q2 | — | 354 | 5% | Society for Translational Medicine (STM) | Profile |
| 95 | Breast Cancer Research and Treatment ISSN: 0167-6806 / 1573-7217 | 🇺🇸United States | Q2 | CAS Tier 3 | 3.3 | 1.34Q1 | 139 | 398 | 6.7% | Springer US | Profile |
| 96 | Journal of Cancer Research and Clinical Oncology ISSN: 0171-5216 / 1432-1335 | 🇩🇪Germany | Q2 | CAS Tier 3 | 3.3 | 0.954Q1 | 87 | 362 | 3.7% | Springer Berlin Heidelberg | Profile |
| 97 | Lung Cancer: Targets and Therapy ISSN: 1179-2728 | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 3.3 | — | — | 8 | N/A | Dove Medical Press | Profile |
| 98 | Blood and Lymphatic Cancer-Targets and Therapy ISSN: 1179-9889 | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 3.2 | — | — | 6 | 0% | Dove Medical Press | Profile |
| 99 | Infectious Agents and Cancer ISSN: 1750-9378 | 🇬🇧United Kingdom | Q3 | CAS Tier 3 | 3.2 | 0.92Q2 | 30 | 66 | 3.2% | BioMed Central | Profile |
| 100 | American Journal of Cancer Research ISSN: 2156-6976 | 🇺🇸United States | Q2 | CAS Tier 3 | 3.1 | — | 20 | 381 | 2.8% | E-CENTURY PUBLISHING CORP | Profile |